A study of mepolizumab as add-on treatment for COPD exacerbations.

• Research type

  Research Study

• Full title

  Study MEA117113: Mepolizumab vs. Placebo as add-on treatment for frequently exacerbating COPD patients characterized by eosinophil level.

• IRAS ID

  149170

• Contact name

  Ian Pavord

• Contact email

  ian.pavord@ndm.ox.ac.uk

• Sponsor organisation

  GlaxoSmithKline Research

• Eudract number

  2013-004297-98

• REC name

  East Midlands - Nottingham 2 Research Ethics Committee

• REC reference

  14/EM/0142

• Date of REC Opinion

  9 May 2014

• REC opinion

  Favourable Opinion